Want to join the conversation?
$LH's largest contributing segment LabCorp Diagnostics 4Q15 revenue rose 4.3% to $1.55Bil vs. 4Q14, helped by an increase in net revenue due to organic volume growth, Beacon LBS, price, mix & tuck-in acquisitions, partially offset by currency. Covance Drug Development revenue rose 4.7% to $691.4MM vs. 4Q14, due to negative impact of the US dollar.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.